By Angela Greene | Published April 22, 2026 | Category: Living with Lyme
Disclaimer: I am not a doctor. The information in this article is based on my personal experience and research, and is for informational purposes only. If you have been bitten by a tick, please consult a qualified healthcare professional.
A new study just confirmed what thousands of Lyme patients have been saying for years: some of us are wired differently. Our immune systems don’t respond to this infection the way the textbooks say they should. That is not a character flaw or a mystery. It’s genetics.
I wish I had known that two years ago, when a doctor refused to look at the tick I’d pulled from my skin and told me I didn’t have Lyme disease before my test results even came back.
She didn’t like ticks, she said. Before my results arrived, she announced it was cellulitis or something else. She gave me three weeks of doxycycline, which made me violently ill. When I called asking for an alternative antibiotic, they refused. That was it. That was my “care.”
Two years later, I still don’t have a Lyme diagnosis. I still don’t have a doctor managing this. Every test has come back negative, even though everything in my body changed after that tick bite. My A1C shot up. My inflammation markers skyrocketed. My ANA went from mildly elevated to 1:320, an eight-fold increase that no one told me about until I ended up in the emergency room last October.
I’ve been on a waiting list to see a rheumatologist since that ER visit. It will have taken eight months, from October 2025 to June 2026, just to get an appointment. This is what “healthcare” looks like when your illness doesn’t fit the textbook.
If you’re reading this, chances are you know exactly what I’m talking about. You’ve been dismissed. You’ve been told your symptoms don’t make sense. You’ve wondered if you’re losing your mind or if it really is all in your head. This research is for you.
The Research That Changed Everything
In March 2026, researchers at Tufts University published a study in the journal Frontiers in Immunology that fundamentally shifts how we understand Lyme disease recovery. The research, supported by the Global Lyme Alliance, reveals that genetic differences in immune system function – specifically variations in a gene called TLR1 – may help explain why some people develop prolonged Lyme disease complications while others recover quickly after treatment.
When I first read this study, something inside me unclenched. For the first time since that tick bite, I had a scientific explanation for why my experience didn’t match what the textbooks said should happen.
What the TLR1 Gene Does (And Why It Matters)
The TLR1 gene plays a critical role in how your immune system recognizes bacteria, including Borrelia burgdorferi, the bacterium that causes Lyme disease. Think of it as one of your body’s alarm systems – when bacteria enters your body, TLR1 helps sound the alert so your immune system can mount a defense.
But not everyone’s alarm system is calibrated the same way. The Tufts research found that people with certain TLR1 genetic variations tend to have significantly stronger inflammatory responses during early Lyme infection. While inflammation is a normal and necessary part of fighting infection, an overly aggressive inflammatory response can cause problems that persist even after the bacteria is gone.
Here’s what the researchers discovered:
- Heightened early inflammation: People with specific TLR1 variations showed stronger inflammatory responses when first infected with Lyme disease
- Persistent immune activation: This inflammation didn’t necessarily calm down after antibiotic treatment the way it did in people without the variation
- Increased arthritis risk: The genetic variation was linked to higher rates of Lyme arthritis that continued even after bacteria were treated with antibiotics
- Impaired immune tolerance: The immune system struggled to “turn off” the inflammatory response, leading to ongoing symptoms
Importantly, this study shows an association between TLR1 variation and increased inflammation – not a direct cause-and-effect relationship. More research is needed to fully understand how TLR1 and other genes influence Lyme disease outcomes. But the implications are already profound.
Why This Matters If You’re Still Sick
For two years, I’ve been told my symptoms should have resolved. For two years, I’ve fought to be taken seriously by doctors who couldn’t understand why I wasn’t following the expected recovery pattern. This research finally validates what I – and thousands of other Lyme patients – have been saying all along: our bodies are responding differently, and it’s not because we’re weak or making it up.
As Dr. Armin Alaedini, Chief Scientific Officer at the Global Lyme Alliance, explained in their research update, “Evidence emerging from this study helps clarify why some patients continue to experience long-term symptoms while others recover more quickly, pointing to differences in immune response rather than the infection alone.”
Read that again, differences in immune response, rather than the infection alone.
This isn’t about whether you got treatment fast enough (though that matters). This isn’t about whether you’re following your treatment plan correctly (though that matters too). This is about fundamental differences in how individual immune systems are wired to respond to Borrelia burgdorferi.
The Bigger Picture: Immune Genetics and Chronic Lyme
The TLR1 findings are part of a larger shift in how researchers understand post-treatment Lyme disease syndrome (PTLDS) and chronic Lyme disease. For years, the medical establishment has struggled to explain why 10-20% of Lyme patients continue to experience symptoms long after standard antibiotic treatment.
The dominant theories have included:
- Persistent infection: Bacteria remaining in the body despite antibiotic treatment
- Autoimmune response: The immune system attacking the body’s own tissues after being triggered by infection
- Tissue damage: Permanent damage caused by the initial infection
- Dysregulated immune response: The immune system failing to properly “turn off” after the infection is cleared
This new genetic research supports the dysregulated immune response theory while adding an important piece: some people may be genetically predisposed to this type of prolonged inflammatory response. Your genes may influence not just whether you get sick, but how sick you get and how long you stay sick.
Dr. Alaedini noted that research into immune-system genetics is “central to understanding the biological drivers of prolonged inflammation.” As this field advances, we’re moving closer to understanding why Lyme disease outcomes differ so dramatically from person to person – and potentially, how care might one day be individually tailored based on genetic profiles.
What This Means for Your Treatment
Right now, genetic testing for TLR1 variations isn’t part of standard Lyme disease care. This research is still new, and scientists are still working to understand exactly how these genetic factors interact with infection, treatment, and outcomes. But even without a genetic test, this research changes the conversation you can have with your doctor.
If your doctor dismisses your ongoing symptoms, you now have peer-reviewed research showing that genetic differences in immune function may explain prolonged recovery. This isn’t “all in your head” – it’s in your genes.
If you’re being told you should be better by now, you can point to evidence that some immune systems are wired to mount more aggressive inflammatory responses that don’t easily resolve.
If you’re blaming yourself for not recovering, you can stop. Your immune system’s response to Borrelia burgdorferi may be fundamentally different from the textbook case, and that’s not your fault.
This is exactly why finding a Lyme-literate doctor matters so much. A physician who understands the complexity of Lyme disease – including emerging research on immune genetics – is more likely to take your symptoms seriously, explore treatment options beyond the standard protocols, and work with you as a partner rather than dismissing your experience.
The Path Forward
I still don’t have a Lyme disease diagnosis. Every test has been negative. But I know my body, and I know everything changed after that tick bite two years ago. I’m waiting for a rheumatology appointment that’s taken eight months to schedule. I don’t know if I carry a TLR1 variation. I don’t know if what I’m experiencing is post-treatment Lyme disease syndrome, an autoimmune condition triggered by the infection, or something else entirely.
What I do know is this: I was dismissed when I had every classic sign. I was told I didn’t have Lyme before the tests even came back. My inflammation markers tell a story my doctors refused to hear. And I’m far from alone in this experience.
Research like the Tufts TLR1 study is slowly building the scientific foundation that will force mainstream medicine to take patients like us seriously. Every study that identifies a biological mechanism – whether genetic, immunological, or microbiological – makes it harder for doctors to dismiss us as psychiatric cases or hypochondriacs.
We deserve better. We deserve doctors who understand that immune responses vary. We deserve treatment protocols that account for individual differences. We deserve to be believed when we say our bodies changed after a tick bite, even when the tests come back negative.
And while we wait for medicine to catch up with the research, we can keep educating ourselves, advocating for ourselves, and supporting each other.
Resources and Next Steps
If you’re struggling to find appropriate medical care for Lyme disease, you’re not alone. Here are some steps that can help:
Find a Lyme-literate doctor: Use our Virginia Lyme Doctors Directory to locate physicians who understand the complexities of Lyme disease, including chronic and post-treatment presentations. These doctors are more likely to be familiar with emerging research on immune genetics and individual variation in disease outcomes.
Stay informed: Subscribe to our email list to get updates on the latest Lyme disease research, treatment options, and resources delivered directly to your inbox.
Track your symptoms: Documenting your symptoms over time can help you identify patterns and provide concrete data when discussing your case with healthcare providers.
Connect with advocacy organizations: Groups like the Global Lyme Alliance, ILADS, and LymeDisease.org provide patient resources, fund research, and work to improve medical education about Lyme disease.
You’re not imagining your symptoms. You’re not weak. Your immune system may simply be wired differently – and that difference is finally starting to be recognized by science.
Frequently Asked Questions
Can I get tested for TLR1 genetic variations?
Currently, testing for TLR1 variations is not part of standard clinical care for Lyme disease. This research is still relatively new, and more studies are needed before genetic testing becomes a routine part of Lyme diagnosis or treatment planning. If you’re interested in genetic testing related to immune function, discuss options with a Lyme-literate doctor who can evaluate whether existing genetic tests might provide useful information for your specific case.
Does having a TLR1 variation mean I’ll definitely develop chronic Lyme?
No. The research shows an association between certain TLR1 variations and increased risk of prolonged symptoms and post-infectious arthritis, but it doesn’t mean everyone with the variation will develop chronic issues. Many factors influence Lyme disease outcomes, including how quickly you’re diagnosed and treated, the strain of bacteria involved, your overall health, and other genetic and environmental factors. Think of genetic variations as one piece of a complex puzzle, not a guaranteed outcome.
If genetics play a role, does that mean antibiotics won’t work for me?
Not at all. Antibiotics remain the primary treatment for Lyme disease and are effective at killing Borrelia burgdorferi bacteria. What this research suggests is that even after successful bacterial clearance, some people’s immune systems may continue to mount inflammatory responses that cause ongoing symptoms. This doesn’t mean antibiotics failed – it means your immune system may need additional support to properly regulate inflammation after the infection is treated. A Lyme-literate doctor can help develop a comprehensive treatment plan that addresses both the infection and immune dysregulation.
What is the difference between chronic Lyme and post-treatment Lyme disease syndrome (PTLDS)?
The terminology can be confusing, and different medical organizations use different terms. Post-treatment Lyme disease syndrome (PTLDS) is the term used by organizations like the CDC and refers to symptoms that persist for more than 6 months after standard antibiotic treatment. “Chronic Lyme disease” is a broader term often used by patients and Lyme-literate practitioners to describe ongoing illness related to Lyme disease, which may or may not have been adequately treated initially. Some doctors distinguish between active, persistent infection and post-infectious immune complications. This genetic research helps explain why some people develop prolonged symptoms regardless of terminology, suggesting that immune system differences may drive ongoing inflammation even after bacteria are cleared.
Are there other genes besides TLR1 that affect Lyme disease outcomes?
Yes, researchers believe multiple genes are likely involved in determining how individuals respond to Lyme disease. TLR1 is part of a larger family of toll-like receptors that help the immune system recognize pathogens. Other genes involved in immune regulation, inflammation control, and tissue repair may also play roles in disease severity and recovery. Research in this area is ongoing, and scientists are working to identify additional genetic factors that influence Lyme disease outcomes. The goal is to eventually develop a more complete picture of how genetic variation affects both susceptibility to severe disease and recovery trajectory.
How can I advocate for myself if my doctor doesn’t believe in chronic Lyme?
This is one of the most challenging aspects of Lyme disease care. Start by bringing published research, like the Tufts TLR1 study, to your appointments. Frame your symptoms in terms of objective findings when possible – joint swelling, documented fatigue levels, cognitive testing results. If your doctor remains dismissive, seeking a second opinion or finding a Lyme-literate physician may be necessary. Patient advocacy organizations like ILADS and LymeDisease.org provide resources specifically designed to help patients communicate with skeptical healthcare providers. Remember that you have the right to be taken seriously and to seek care from physicians who acknowledge the complexity of Lyme disease.
Will there eventually be personalized treatment based on genetics?
That’s the hope, though we’re not there yet. As research continues to identify genetic factors that influence Lyme disease outcomes, the medical field may eventually move toward more personalized treatment approaches. This could include using genetic information to predict who might need more aggressive initial treatment, who might benefit from anti-inflammatory therapies in addition to antibiotics, or who might need closer monitoring for post-treatment complications. However, this type of precision medicine for Lyme disease is still years away. For now, the most important takeaway is that genetic research validates what patients have been reporting – that individual differences in immune response play a real, measurable role in disease outcomes.
Does this research apply to other tick-borne diseases besides Lyme?
While this specific study focused on Lyme disease and Borrelia burgdorferi, the principle that genetic variations in immune function affect disease outcomes likely applies to other tick-borne infections as well. Diseases like anaplasmosis, babesiosis, and bartonellosis also trigger immune responses, and individual variation in immune genetics could influence how people respond to these infections. However, specific research would need to be conducted for each disease to understand which genetic factors matter and how they affect outcomes. If you’ve been diagnosed with co-infections in addition to Lyme disease, discuss with your doctor how immune dysregulation might be affecting your overall symptom picture.
Medical Disclaimer
The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call your doctor or 911 immediately. Track Your Lyme does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on this site. Reliance on any information provided by Track Your Lyme is solely at your own risk.
References and Citations
- Williams, M. A., Hernandez, S. A., Arvikar, S. L., Sulka, K. B., Strle, F., Wells, C. C., Petnicki-Ocwieja, T., Steere, A. C., & Strle, K. (2025). Toll-like receptor 1 polymorphism is associated with impaired immune tolerance, dysregulated inflammatory responses to Borrelia burgdorferi, and heightened risk of post-infectious Lyme arthritis. Frontiers in Immunology, 16, 1711765. https://doi.org/10.3389/fimmu.2025.1711765
- Global Lyme Alliance. (2026, March 27). GLA Research Update: New Study Suggests Genetics May Influence Lingering Lyme Symptoms. Retrieved from https://www.globallymealliance.org
- Centers for Disease Control and Prevention. (2025). Chronic Symptoms and Lyme Disease. https://www.cdc.gov/lyme/signs-symptoms/chronic-symptoms-and-lyme-disease.html
- International Lyme and Associated Diseases Society (ILADS). (2014). Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes, and persistent disease. https://www.ilads.org/patient-care/ilads-treatment-guidelines/
- LymeDisease.org. (2024). Chronic Lyme Disease. https://www.lymedisease.org/lyme-basics/lyme-disease/chronic-lyme/
Need Help Finding a Lyme-Literate Doctor?
Finding a physician who understands the complexity of Lyme disease – including emerging research on genetics and immune response – can make all the difference in your treatment journey.Browse our Virginia Lyme Doctors Directory to find Lyme-literate practitioners in your area who take chronic and post-treatment Lyme disease seriously.